|
SRS16-86
- 英文名称：SRS16-86
- 品牌：WYTSCI
- 产地：进口
- 型号：1MG
- 货号：WT-AY-B11352
- cas：1793052-96-6
- 价格： ￥1/mg
- 发布日期： 2025-04-10
- 更新日期： 2025-05-23
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B11352 |
| 用途 | 科研检测 |
| 英文名称 | SRS16-86 |
| 包装规格 | 1MG |
| CAS编号 | 1793052-96-6 |
| 别名 | SRS16-86 |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:>98% by TLC (NMR Conforms)
分子式:C26H32N4O2
分子量:432.57
溶剂:DMSO (25 mg/ml)
性状:Yellow solid
存储:-20°C
Activity (short version):Lipid peroxidation inhibitor
Function / Pharmacology:SRS16-86 is a third generation ferrostatin derivative with greater metabolic and plasma stability for in vivo studies. It protected mice in a renal severe ischemia-reperfusion injury model via inhibition of ferroptosis.1 SRS16-86 enhanced functional recovery after spinal cord injury in a rat model via upregulation of GPX4, GSH, and xCT as well as downregulation of lipid peroxidation marker 4-hydroxynonenal.2
分子式:C26H32N4O2
分子量:432.57
溶剂:DMSO (25 mg/ml)
性状:Yellow solid
存储:-20°C
Activity (short version):Lipid peroxidation inhibitor
Function / Pharmacology:SRS16-86 is a third generation ferrostatin derivative with greater metabolic and plasma stability for in vivo studies. It protected mice in a renal severe ischemia-reperfusion injury model via inhibition of ferroptosis.1 SRS16-86 enhanced functional recovery after spinal cord injury in a rat model via upregulation of GPX4, GSH, and xCT as well as downregulation of lipid peroxidation marker 4-hydroxynonenal.2
